{"nct_id":"NCT07100080","title":"Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)","status":"NOT_YET_RECRUITING","status_verified_date":"2025-10","start_date":"2025-10-15","start_date_type":"ESTIMATED","primary_completion_date":"2028-09-15","primary_completion_date_type":"ESTIMATED","completion_date":"2031-05-15","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["BMY"]}